Role of acid suppression in acid-related diseases: Proton pump inhibitor and potassium-competitive acid blocker

Hideki Mori, Hidekazu Suzuki

研究成果: Review article査読

19 被引用数 (Scopus)

抄録

Proton pump inhibitors are commonly utilized for the treatment of gastric acid-related diseases, such as gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection, and for the prevention of low-dose aspirin or nonsteroidal anti-inflammatory drug-induced peptic ulcers. Vonoprazan is a first-in-class potassium-competitive acid blocker, which has distinct advantages compared to other conventional proton pump inhibitors in terms of the efficacy for acid suppression. Due to its strong gastric acid suppression capabilities, vonoprazan serves as an effective drug for the treatment of gastroesophageal reflux disease and H. pylori infection.

本文言語English
ページ(範囲)6-14
ページ数9
ジャーナルJournal of Neurogastroenterology and Motility
25
1
DOI
出版ステータスPublished - 2019 1 1

ASJC Scopus subject areas

  • 臨床神経学
  • 消化器病学

フィンガープリント

「Role of acid suppression in acid-related diseases: Proton pump inhibitor and potassium-competitive acid blocker」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル